InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
T+90 hit rate
43%
T+90 mean return
-3.0%
Across 21 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Elting Kimberley A., Directrice Juridique et Développement. Insider active across 2 companies, notably Orthofix Medical Inc.. In total, 30 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €54k. Activity tracked since 3 July 2021. The latest transaction was filed on 8 June 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations30 total
4,267 shares@ US$13.4211.2% of flowCommon StockSEC:0000950170-24-072487:0
2,938 shares@ US$13.958.1% of flowCommon StockSEC:0000950170-24-044085:0
2,031 shares@ US$14.065.6% of flowCommon StockSEC:0000950170-24-041302:0
2,015 shares@ US$14.275.6% of flowCommon StockSEC:0000950170-24-011265:0
5,228 shares@ US$12.6712.8% of flowCommon StockSEC:0001209191-24-001245:0
1,778 shares@ US$12.964.5% of flowCommon StockSEC:0001209191-24-001032:0
47,664 shares0Common StockSEC:0001209191-23-056400:0
2,938 shares@ US$17.7710.2% of flowCommon StockSEC:0001209191-23-024131:0
2,385 shares@ US$16.757.8% of flowCommon StockSEC:0001209191-23-023448:0
2,015 shares@ US$21.548.5% of flowCommon StockSEC:0001209191-23-007205:0
35,129 shares0Common StockSEC:0001209191-23-002664:0
11,710 shares0Common StockSEC:0001209191-23-002113:0
365 shares@ US$19.531.5% of flowCommon StockSEC:0001209191-22-049010:0
29,874 shares0Common StockSEC:0001209191-22-024288:0
354 shares@ US$33.040.0017% mcap9.3% of flowCommon StockSEC:0001209191-22-023337:0
20,492 shares0Common StockSEC:0001209191-22-006837:0
20,492 shares0Common StockSEC:0001209191-22-006837
1,000 shares@ US$30.345.7% of flowCommon StockSEC:0001209191-21-065545
Canonical exit: 16 Feb 2022 (T+90)
1,000 shares@ US$30.340.0044% mcap23.5% of flowCommon StockSEC:0001209191-21-065545:0
Canonical exit: 16 Feb 2022 (T+90)
365 shares@ US$42.690.0022% mcap11.5% of flowCommon StockSEC:0001209191-21-055054:0
365 shares@ US$42.692.8% of flowCommon StockSEC:0001209191-21-055054
346 shares@ US$40.480.0020% mcap10.4% of flowCommon StockSEC:0001209191-21-045860:0
346 shares@ US$40.482.5% of flowCommon StockSEC:0001209191-21-045860
4,898 sharesCommon StockSEC:0001562180-16-001515:1
10,102 sharesCommon StockSEC:0001562180-16-001515:2
25 of 30 declarations
About Elting Kimberley A.
Kimberley A. Elting is the Chief Legal & Development Officer and President of Global Orthopedics at Orthofix Medical Inc. She is responsible for managing legal affairs and the strategic development of the company. Her role involves ensuring regulatory compliance and aligning development objectives. With her expertise, she contributes to the overall performance of the company.
